Chiesi appoints David Khougazian as group CEO

David Khougazian will become Group Chief Executive Officer of Chiesi on October 15, succeeding interim CEO Jean-Marc Bellemin. Chiesi’s announcement says Bellemin will continue as Group CFO, while Il Sole 24 Ore reports that Khougazian brings more than 25 years across healthcare and life sciences.\n\nKhougazian joins from Flagship Pioneering, where he was executive partner for growth and head of global engagement. Chiesi said the board’s selection process was designed to find a leader for the next phase of innovation-driven growth, including stronger capabilities, pipeline development and partnerships.\n\nA healthcare operator with a platform mandate\n\nThe incoming CEO’s background sits at the intersection of science-led companies, financing and organizational development. At Flagship, he worked with leadership teams on long-term value creation and supported the growth of healthcare businesses, experience Chiesi says it wants to carry into its next chapter.\n\nKhougazian’s arrival follows Legend Biotech’s appointment of Ingrid Zhang, another healthcare transition where the board framed the next CEO’s brief around innovation and a growing pipeline.